92 related articles for article (PubMed ID: 1713462)
1. High prostaglandin-E1 binding to serum protein in allergic subjects.
Maehira F
Biochem Pharmacol; 1991 Jul; 42(3):609-15. PubMed ID: 1713462
[TBL] [Abstract][Full Text] [Related]
2. Binding sites of fluorescent probes on human serum albumin.
Muller N; Lapicque F; Drelon E; Netter P
J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
[TBL] [Abstract][Full Text] [Related]
3. Alteration of salicylate binding to serum protein in allergic subjects.
Maehira F; Nakada F; Hirayama K
Clin Physiol Biochem; 1990; 8(6):322-32. PubMed ID: 2132168
[TBL] [Abstract][Full Text] [Related]
4. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
Thumser AE; Buckland AG; Wilton DC
J Lipid Res; 1998 May; 39(5):1033-8. PubMed ID: 9610770
[TBL] [Abstract][Full Text] [Related]
5. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
Panjehshahin MR; Bowmer CJ; Yates MS
Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
[TBL] [Abstract][Full Text] [Related]
6. Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin.
Kragh-Hansen U
Biochem J; 1983 Jan; 209(1):135-42. PubMed ID: 6847607
[TBL] [Abstract][Full Text] [Related]
7. A comparison of drug binding sites on mammalian albumins.
Panjehshahin MR; Yates MS; Bowmer CJ
Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
[TBL] [Abstract][Full Text] [Related]
8. Effect of late pregnancy on salicylate, diazepam, warfarin, and propranolol binding: use of fluorescent probes.
Yoshikawa T; Sugiyama Y; Sawada Y; Iga T; Hanano M; Kawasaki S; Yanagida M
Clin Pharmacol Ther; 1984 Aug; 36(2):201-8. PubMed ID: 6744779
[TBL] [Abstract][Full Text] [Related]
9. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
Wanwimolruk S; Birkett DJ
Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for drug binding to site II on human serum albumin.
Wanwimolruk S; Birkett DJ; Brooks PM
Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
[TBL] [Abstract][Full Text] [Related]
11. A novel binding site for bile acids on human serum albumin.
Takikawa H; Sugiyama Y; Hanano M; Kurita M; Yoshida H; Sugimoto T
Biochim Biophys Acta; 1987 Nov; 926(2):145-53. PubMed ID: 2444264
[TBL] [Abstract][Full Text] [Related]
12. D-galactosamine-induced cell damage enhances specific binding of prostaglandin E1 to rat hepatocytes.
Matsumoto M; Kikuchi E; Okamoto Y; Morimura M; Kitano H; Fukui H; Nakano H; Tsujii T
Biochem Biophys Res Commun; 1992 Apr; 184(2):654-60. PubMed ID: 1315527
[TBL] [Abstract][Full Text] [Related]
13. Drug binding sites on chicken albumin: a comparison to human albumin.
Rajaian H; Symonds HW; Bowmer CJ
J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
Kragh-Hansen U
Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
[TBL] [Abstract][Full Text] [Related]
15. The interaction of human serum albumin with a novel antidiabetic agent--SU-118.
Zhong W; Wang Y; Yu JS; Liang Y; Ni K; Tu S
J Pharm Sci; 2004 Apr; 93(4):1039-46. PubMed ID: 14999739
[TBL] [Abstract][Full Text] [Related]
16. Drug-protein binding kinetics in patients with type I diabetes.
Wörner W; Preissner A; Rietbrock N
Eur J Clin Pharmacol; 1992; 43(1):97-100. PubMed ID: 1380461
[TBL] [Abstract][Full Text] [Related]
17. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin.
Wang R; Nelson JC; Wilcox RB
Thyroid; 1999 Apr; 9(4):359-64. PubMed ID: 10319941
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin-E1-binding sites in rabbit erythrocyte membranes.
Dutta-Roy AK; Hoque L; Paterson BJ
Eur J Biochem; 1993 May; 213(3):1167-73. PubMed ID: 8504810
[TBL] [Abstract][Full Text] [Related]
19. Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin.
Dengler TJ; Robertz-Vaupel GM; Dengler HJ
Eur J Clin Pharmacol; 1992; 43(5):491-9. PubMed ID: 1282889
[TBL] [Abstract][Full Text] [Related]
20. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
Ozer I; Tacal O
Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
